Taiwan Exosome Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Taiwan Exosome General Information
Description
Developer of regenerative biotechnology products designed for healthcare and aesthetic applications. The company's technology platform integrates human, animal, and plant-derived exosome isolation, purification, and mass production capabilities, providing pharmaceutical and medical aesthetic markets with clinical-grade vesicles for targeted drug delivery and tissue repair.
Contact Information
Website
www.twexosome.comCorporate Office
- 14 Floor-3, No. 3, Yuanqu Street
- Nangang District
- Taipei, 115
- Taiwan
Corporate Office
- 14 Floor-3, No. 3, Yuanqu Street
- Nangang District
- Taipei, 115
- Taiwan
Taiwan Exosome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 01-Nov-2026 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Apr-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Taiwan Exosome Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Taiwan Cooperative Venture Capital | Corporate Venture Capital | Minority | ||
| National Development Fund of Taiwan | Sovereign Wealth Fund | Minority |
Taiwan Exosome FAQs
-
When was Taiwan Exosome founded?
Taiwan Exosome was founded in 2021.
-
Where is Taiwan Exosome headquartered?
Taiwan Exosome is headquartered in Taipei, Taiwan.
-
What industry is Taiwan Exosome in?
Taiwan Exosome’s primary industry is Biotechnology.
-
Is Taiwan Exosome a private or public company?
Taiwan Exosome is a Private company.
-
What is Taiwan Exosome’s current revenue?
The current revenue for Taiwan Exosome is .
-
Who are Taiwan Exosome’s investors?
Taiwan Cooperative Venture Capital and National Development Fund of Taiwan have invested in Taiwan Exosome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process